{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:29:28Z","timestamp":1791779368796,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01964-8","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:24:39Z","timestamp":1761121479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic value of serum DR-70 levels, a new fibrin-related biomarker, in bladder cancer patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Musab Umeyir","family":"Karakanl\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eren G\u00f6rkem","family":"Kutlut\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre Can","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"\u00d6t\u00fcn\u00e7temur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Merder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"1964_CR1","volume-title":"Global cancer observatory: cancer today","author":"J Ferlay","year":"2024","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2024."},{"issue":"5","key":"1964_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-015-1739-2","volume":"466","author":"E Comp\u00e9rat","year":"2015","unstructured":"Comp\u00e9rat E, Larr\u00e9 S, Roupret M, Neuzillet Y, Pignot G, Quintens H, et al. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch. 2015;466(5):589\u201394.","journal-title":"Virchows Arch"},{"issue":"2","key":"1964_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234\u201341.","journal-title":"Eur Urol"},{"issue":"6","key":"1964_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.neo.7900263","volume":"4","author":"GJ Caine","year":"2002","unstructured":"Caine GJ, Stonelake PS, Lip GYH, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465.","journal-title":"Neoplasia"},{"issue":"3","key":"1964_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"JW Blom","year":"2006","unstructured":"Blom JW, Vanderschoot JPM, Oostindi\u00ebr MJ, Osanto S, Van Der Meer FJM, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006;4(3):529\u201335.","journal-title":"J Thromb Haemost"},{"key":"1964_CR6","doi-asserted-by":"crossref","unstructured":"El Azzouzi M, El Ahanidi H, Hafidi Alaoui C, Chaoui I, Benbacer L, Tetou M, et al. The evaluation of vascular endothelial growth factor A (VEGFA) and VEGFR2 receptor as prognostic biomarkers in bladder cancer. Diagnostics (Basel). 2023.","DOI":"10.3390\/diagnostics13081471"},{"issue":"5 C","key":"1964_CR7","first-page":"4593","volume":"19","author":"NH Chow","year":"1999","unstructured":"Chow NH, Liu HS, Chan SH, Cheng HL, Tzai TS. Expression of vascular endothelial growth factor in primary superficial bladder cancer. Anticancer Res. 1999;19(5 C):4593\u20137.","journal-title":"Anticancer Res"},{"issue":"1","key":"1964_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0094-0143(05)70247-0","volume":"27","author":"A Jones","year":"2000","unstructured":"Jones A, Crew J. Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression. Urol Clin North Am. 2000;27(1):191\u20137.","journal-title":"Urol Clin North Am"},{"issue":"2","key":"1964_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/iju.13271","volume":"24","author":"A Alevizopoulos","year":"2017","unstructured":"Alevizopoulos A, Tyritzis S, Leotsakos I, Anastasopoulou I, Pournaras C, Kotsis P, et al. Role of coagulation factors in urological malignancy: a prospective, controlled study on prostate, renal and bladder cancer. Int J Urol. 2017;24(2):130\u20136.","journal-title":"Int J Urol"},{"issue":"9","key":"1964_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1365-2036.2004.02212.x","volume":"20","author":"A Kerber","year":"2004","unstructured":"Kerber A, Trojan J, Herrlinger K, Zgouras D, Caspary WF, Braden B. The new DR-70 immunoassay detects cancer of the Gastrointestinal tract: a validation study. Aliment Pharmacol Ther. 2004;20(9):983\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"1964_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jcma.2018.01.009","volume":"81","author":"YP Hung","year":"2018","unstructured":"Hung YP, Chen MH, Lin JS, Hsiao CF, Shan YS, Chen YC, et al. The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients. J Chin Med Assoc. 2018;81(7):593\u20138.","journal-title":"J Chin Med Assoc"},{"issue":"6","key":"1964_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.5152\/tjg.2015.0425","volume":"26","author":"M Arhan","year":"2015","unstructured":"Arhan M, Yilmaz H, \u00d6nal IK, Kocabiyik M, Erdal H, Ibi\u015f M. DR-70 as a novel diagnostic biomarker for gastric cancer. Turkish J Gastroenterol. 2015;26(6):480\u20133.","journal-title":"Turkish J Gastroenterol"},{"key":"1964_CR13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/eurheartj\/ehi183","volume":"26","author":"SG Wannamethee","year":"2005","unstructured":"Wannamethee SG, Gordon DO, Lowe A, Gerald Shaper A, Rumley L, Lennon PH, Whincup. Associations between cigarette smoking, pipe\/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005;26:1765\u201373. Issue 17, September.","journal-title":"Eur Heart J"},{"key":"1964_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/5584_2015_127","volume":"858","author":"GE Delgado","year":"2015","unstructured":"Delgado GE, Siekmeier R, Kr\u00e4mer BK, M\u00e4rz W, Kleber ME. Plasma fibrinolysis parameters in smokers and Non-smokers of the Ludwigshafen risk and cardiovascular health (LURIC) study. Adv Exp Med Biol. 2015;858:69\u201377.","journal-title":"Adv Exp Med Biol"},{"issue":"3 Suppl","key":"1964_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0090-4295(84)80108-9","volume":"23","author":"RP Huben","year":"1984","unstructured":"Huben RP. Tumor markers in bladder cancer. Urology. 1984;23(3 Suppl):10\u20134.","journal-title":"Urology"},{"issue":"2","key":"1964_CR16","doi-asserted-by":"publisher","first-page":"e6625","DOI":"10.1016\/j.urolonc.2014.06.008","volume":"33","author":"FA Yafi","year":"2015","unstructured":"Yafi F FA, Brimo, Steinberg J, Aprikian AG, Tanguay S, Kassouf W. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol. 2015;33(2):e6625\u201331.","journal-title":"Urol Oncol"},{"issue":"4","key":"1964_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000527980","volume":"90","author":"J Lobo","year":"2023","unstructured":"Lobo J, Lobo C, Le\u00e7a L, Rodrigues \u00c2, Henrique R, Monteiro P. Evaluation of the implementation and diagnostic accuracy of the Paris classification for reporting urinary cytology in voided urine specimens: a cyto-histological correlation study in a cancer center. Pathobiology. 2023;90(4):233\u201340.","journal-title":"Pathobiology"},{"issue":"12","key":"1964_CR18","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00345-018-2380-x","volume":"36","author":"F Soria","year":"2018","unstructured":"Soria F, Droller MJ, Lotan Y, Gontero P, D\u2019Andrea D, Gust KM, et al. An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World J Urol. 2018;36(12):1981.","journal-title":"World J Urol"},{"issue":"1","key":"1964_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/01971529808005472","volume":"19","author":"D Wu","year":"1998","unstructured":"Wu D, Zhou X, Yang G, Xie Y, Hu M, Wu Z, et al. Clinical performance of the AMDL DR-70 immunoassay kit for cancer detection. J Immunoassay. 1998;19(1):63\u201372.","journal-title":"J Immunoassay"},{"issue":"2","key":"1964_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15321811003617438","volume":"31","author":"AL Small-Howard","year":"2010","unstructured":"Small-Howard AL, Harris H. Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients. J Immunoassay Immunochem. 2010;31(2):131.","journal-title":"J Immunoassay Immunochem"},{"issue":"5","key":"1964_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3892\/br.2014.315","volume":"2","author":"HJ So","year":"2014","unstructured":"So HJ, Hong SI, Lee JK, Chang YH, Kang SJ, Hong YJ. Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer. Biomed Rep. 2014;2(5):737\u201342.","journal-title":"Biomed Rep"},{"key":"1964_CR22","unstructured":"ON THE ISSUE OF NECESSITY TO PERFORM THE DR-70 IMMUNOASSAY PRIOR TO PROSTATE BIOPSY IN PATIENTS WITH HIGH PROSTATE SPECIFIC ANTIGEN LEVEL AND ITS EFFICACY IN PREDICTING THE BIOPSY RESULTS. - PubMed [Internet]. Available from:https:\/\/pubmed.ncbi.nlm.nih.gov\/31687943"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01964-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:24:40Z","timestamp":1761121480000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01964-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01964-8","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. This human study was approved by Prof. Dr. Cemil Tascioglu City Hospital - approval: 2023-92. All adult participants provided written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}